ASGE Annual Postgraduate Course: Clinical Challenges and Real-Time Decision Making in GI Endoscopy (On-demand) | May 2023-Intragastric Balloons and the Transpyloric Shuttle

Video Transcription

Video Summary

The video transcript summarizes the speaker's presentation on primary endoscopic bariatric and metabolic therapy. The speaker introduces Dr. Shelby Sullivan as the first speaker in the session, highlighting her expertise in the field. Dr. Sullivan discusses various intragastric balloons used for weight loss, including Orbera, Obalon, Ellipse, Spatz 3, and Reshape. She explains the procedure for placement and removal of these balloons and discusses their indications and contraindications. The speaker also presents data on weight loss and adverse events associated with these balloons.<br /><br />Dr. Sullivan then explains the Aspire Assist system, a device that allows patients to aspirate gastric contents 20 minutes after a meal, removing 20-30% of the calories consumed. She discusses patient selection, clinical considerations, and the effectiveness of the therapy. Another device, the transpyloric shuttle, is also discussed. Dr. Sullivan provides details on its placement, weight loss outcomes, adverse events, and availability.<br /><br />In conclusion, Dr. Sullivan states that endoscopic bariatric therapies are evidence-based and support weight loss. Although weight loss is lower than with bariatric surgery, the therapies have fewer complications and lower costs.

Asset Subtitle

Shelby Sullivan, MD, FASGE

Keywords

endoscopic bariatric therapy

Dr. Shelby Sullivan

intragastric balloons

weight loss

Aspire Assist system

transpyloric shuttle

evidence-based therapies

complications